Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
investment
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner
Mar 23, 2026 10:35am
New rules, higher stakes: Biopharma plays the long game in 2026
Jan 26, 2026 2:40pm
European investment firm ends activity in the life sciences
Jan 26, 2026 2:25pm
Series B round of $125M will fund Diagonal's move into clinic
Jan 8, 2026 6:30am
Pharma's 'urgent need for reinvention': PwC's call to action
Jan 8, 2026 6:00am
Fierce Pharma
3 biopharma CEOs explain why they are 'authentically optimistic'
Jan 6, 2026 11:54am
